Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy
Explore this paper's citation graph
Summary
It is suggested that serial native T1 and extracellular volume may be novel non‐invasive imaging methods to monitor the treatment response to TTR stabilizers in cardiac amyloidosis and also that tafamidis may be effective in suppressing cardiac progression in TTR amyloids cardiomyopathy with Val30Met mutation.
- Type
- article
- Published
- 2018-11-27
- Cited by
- 16
- References
- 15
- Access
- Open access
- OpenAlex
- https://openalex.org/W2902785666
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:53732656
Keywords
Transthyretin, Medicine, Amyloidosis, Amyloid (mycology), Cardiomyopathy
References
- Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
- Recent progress in the understanding and treatment of transthyretin amyloidosis
- Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
- Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
- Rate of progression of transthyretin amyloidosis.
- Tafamidis for transthyretin familial amyloid polyneuropathy
- Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
- Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
- Unusual case of ATTR amyloidosis with cardiac manifestation and situs inversus totalis
- Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report
- Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
- Predictors of Prognosis in Light-Chain Amyloidosis and Chronological Changes in Cardiac Morphology and Function.
- Recent advances in diagnosis and treatment of cardiac amyloidosis.
- TTR Stabilizers are Associated with Improved Survival in Patients with Transthyretin Cardiac Amyloidosis
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Cited by
- Advances in MRI Applications to Diagnose and Manage Cardiomyopathies
- CMR in Hypertrophic Cardiac Conditions—an Update
- Trends in Diagnostic Imaging of Cardiac Amyloidosis: Emerging Knowledge and Concepts.
- Current evidence on the diagnostic and prognostic role of Native T1 mapping in heart diseases.
- Cardiovascular magnetic resonance (CMR) in restrictive cardiomyopathies
- Heart failure in the last year: progress and perspective
- ¿Por qué necesitamos la información metabólica en las enfermedades cardiovasculares?
- Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)
- Why do we need metabolic information in cardiovascular diseases?
- Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis, Prognosis, and Treatment of Infiltrative Cardiomyopathies
- Multimodality imaging approach to cardiac amyloidosis: part 2
- Imaging-Guided Treatment for Cardiac Amyloidosis
- A Review of Current and Evolving Imaging Techniques in Cardiac Amyloidosis
- Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis
- Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
- Tafamidis decreased cardiac amyloidosis deposition in patients with Ala97Ser hereditary transthyretin cardiomyopathy: a 12-month follow-up cohort study
Related papers
- Cardiac Transthyretin Amyloidosis With Coincident Paget’s Disease: A Case Report
- Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
- Clinical characteristics of patients with cardiac amyloidosis in Sarawak: Comparison between transthyretin and light-chain amyloid cardiomyopathy
- Role of Cardiac Magnetic Resonance in the Diagnosis of Cardiac Amyloidosis
- Pathophysiology and treatment of cardiac amyloidosis
- Cardiac amyloidosis in 2023: A review of pathophysiology, diagnosis, and treatment
- A new era in treatment of cardiac amyloidosis: an overview of the Congress of cardiology
- [AL-amyloidosis with cardiac involvement. Diagnostic capabilities of non-invasive methods].